MiMedx Group, headquartered in Marietta, Georgia, specializes in therapeutic biologics, focusing on placental tissue allografts for wound care and surgical applications. The company, founded in 2007, employs 895 staff and offers various patented products.
Mimedx Group (MDXG) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Mimedx Group's actual EPS was $0.06, beating the estimate of $0.06 per share, resulting in a 6.95% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
